Drugs / Piperacillin/Tazobactam
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01517815 | Feb 2012 → Jun 2013 | infectious disease with sepsis | University Hospital, Montpellier | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/Tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01517815 ↗ |
| Route | Intravenous | “Piperacillin/Tazobactam 4g IV (1h) and then 16g/24h IV continuously whatever the patient's weight.” NCT01517815 ↗ |